Citizens Jmp Initiates Coverage on Assembly Biosciences (NASDAQ:ASMB)

Citizens Jmp started coverage on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a report published on Wednesday, Marketbeat.com reports. The firm issued a mkt outperform rating and a $38.00 target price on the biopharmaceutical company’s stock. A number of other research firms have also recently weighed in on ASMB. HC Wainwright started coverage […]

Leave a Reply

Your email address will not be published.

Previous post UBS Group Issues Positive Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price
Next post JPMorgan Chase & Co. Increases ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $115.00